HM
Hernandez Marlow PDG
C-suite M
US US · SEC (Form 4)
Browse the detailed record of transactions filed by Hernandez Marlow, PDG. Officer active across 1 companies, notably Cano Health, Inc.. Cumulatively, 20 disclosures have been published. Total volume traded: €4m. The latest transaction was disclosed on 26 May 2022 — C. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 20 total
011,017,311 shares 0
Class A Common Stock
SEC:0000899243-22-020172:0 · 26 May 2022
624,418 shares
Class A Common Stock
SEC:0000899243-22-011466:0 · 15 Mar 2022
€106,150 15,000 shares @ €7.0766 3.5% of flow
Class A Common Stock
SEC:0000899243-21-047185 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) €106,150 15,000 shares @ €7.0766 1.7% of flow
Class A Common Stock
SEC:0000899243-21-047185:0 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) €96,739 12,500 shares @ €7.7391 3.2% of flow
Class A Common Stock
SEC:0000899243-21-046941 · 3 Dec 2021
Ideal exit: 30 Aug 2022 (T+270) €96,739 12,500 shares @ €7.7391 1.6% of flow
Class A Common Stock
SEC:0000899243-21-046941:0 · 3 Dec 2021
Ideal exit: 30 Aug 2022 (T+270) €68,466 8,000 shares @ €8.5582 2.2% of flow
Class A Common Stock
SEC:0000899243-21-046067 · 22 Nov 2021
Ideal exit: 19 Aug 2022 (T+270) €68,466 8,000 shares @ €8.5582 1.1% of flow
Class A Common Stock
SEC:0000899243-21-046067:0 · 22 Nov 2021
Ideal exit: 19 Aug 2022 (T+270) 1,339,500 shares
Class A Common Stock
SEC:0000899243-21-037547 · 21 Sept 2021
1,339,500 shares
Class A Common Stock
SEC:0000899243-21-037547:0 · 21 Sept 2021
€59,218 5,833 shares @ €10.1522 1.9% of flow
Class A Common Stock
SEC:0000899243-21-034907 · 31 Aug 2021
Ideal exit: 28 May 2022 (T+270) €59,218 5,833 shares @ €10.1522 1.0% of flow
Class A Common Stock
SEC:0000899243-21-034907:0 · 31 Aug 2021
Ideal exit: 28 May 2022 (T+270) €554,502 54,727 shares @ €10.1321 18.2% of flow
Class A Common Stock
SEC:0000899243-21-034612 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €554,502 54,727 shares @ €10.1321 9.1% of flow
Class A Common Stock
SEC:0000899243-21-034612:0 · 25 Aug 2021
Ideal exit: 22 May 2022 (T+270) €99,850 11,900 shares @ €8.3908 3.3% of flow
Class A Common Stock
SEC:0000899243-21-033963 · 18 Aug 2021
Ideal exit: 15 May 2022 (T+270) €1m 120,000 shares @ €8.6248 33.9% of flow
Class A Common Stock
SEC:0000899243-21-033876 · 16 Aug 2021
Ideal exit: 13 May 2022 (T+270) €99,850 11,900 shares @ €8.3908 1.6% of flow
Class A Common Stock
SEC:0000899243-21-033963:0 · 18 Aug 2021
Ideal exit: 15 May 2022 (T+270) €1m 120,000 shares @ €8.6248 16.9% of flow
Class A Common Stock
SEC:0000899243-21-033876:0 · 16 Aug 2021
Ideal exit: 13 May 2022 (T+270) €1m 120,000 shares @ €8.6248 33.9% of flow
Class A Common Stock
SEC:0000899243-21-033441 · 16 Aug 2021
€1m 120,000 shares @ €8.6248 16.9% of flow
Class A Common Stock
SEC:0000899243-21-033441:0 · 16 Aug 2021
About Hernandez Marlow Hernandez Marlow is an executive at Cano Health, Inc.